Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

MJ Millan, A Dekeyne, A Gobert, M Brocco… - …, 2020 - Elsevier
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …
被引用次数：23 相关文章

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

MJ Millan, A Dekeyne, A Gobert… - …, 2020 - pubmed.ncbi.nlm.nih.gov
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.

MJ Millan, A Dekeyne, A Gobert, M Brocco… - …, 2020 - europepmc.org
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

MJ Millan, A Dekeyne, A Gobert… - … - nottingham-repository.worktribe.com
© 2020 Elsevier Ltd To date, there are no interventions that impede the inexorable
progression of Alzheimer's disease (AD), and currently-available drugs cholinesterase …
[PDF] core.ac.uk

[PDF][PDF] Jean-Claude Ortuno**, David Watson*** and Kevin CF Fone**** Centre for Therapeutic Innovation in Neuropsychiatry, Institut de recherche Servier, 78290 …

MJ Millan, A Dekeyne, A Gobert, M Brocco, CM la Cour - core.ac.uk
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

MJ Millan, A Dekeyne, A Gobert, M Brocco… - …, 2020 - hero.epa.gov
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.

MJ Millan, A Dekeyne, A Gobert, M Brocco… - …, 2020 - psycnet.apa.org
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …
[PDF] worktribe.com

[PDF][PDF] Jean-Claude Ortuno**, David Watson*** and Kevin CF Fone**** Centre for Therapeutic Innovation in Neuropsychiatry, Institut de recherche Servier, 78290 …

MJ Millan, A Dekeyne, A Gobert, M Brocco, CM la Cour - nottingham-repository.worktribe.com
To date, there are no interventions that impede the inexorable progression of Alzheimer's
disease (AD), and currently-available drugs cholinesterase (AChE) inhibitors and the N …